These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11862375)

  • 1. Diagnosis at the first episode to differentiate antidepressant treatment responses in patients with mood and anxiety disorders.
    de Kemp EC; Moleman P; Hoogduin CA; Broekman TG; Goedhart A; Schaap CP; van den Berg PC
    Psychopharmacology (Berl); 2002 Feb; 160(1):67-73. PubMed ID: 11862375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of fluvoxamine, imipramine, and placebo in the treatment of outpatients with panic disorder.
    Nair NP; Bakish D; Saxena B; Amin M; Schwartz G; West TE
    Anxiety; 1996; 2(4):192-8. PubMed ID: 9160622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluvoxamine versus imipramine and placebo: a double-blind comparison in depressed patients.
    Fabre L; Birkhimer LJ; Zaborny BA; Wong LF; Kapik BM
    Int Clin Psychopharmacol; 1996 Jun; 11(2):119-27. PubMed ID: 8803649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant apathy syndrome.
    Lee SI; Keltner NL
    Perspect Psychiatr Care; 2005; 41(4):188-92. PubMed ID: 16297025
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of two-phase treatment with imipramine or fluvoxamine, both followed by lithium addition, in inpatients with major depressive disorder.
    Birkenhäger TK; van den Broek WW; Mulder PG; Bruijn JA; Moleman P
    Am J Psychiatry; 2004 Nov; 161(11):2060-5. PubMed ID: 15514407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of fluvoxamine in the treatment of major depression with comorbid anxiety disorders.
    Sonawalla SB; Spillmann MK; Kolsky AR; Alpert JE; Nierenberg AA; Rosenbaum JF; Fava M
    J Clin Psychiatry; 1999 Sep; 60(9):580-3. PubMed ID: 10520975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind randomized study comparing imipramine with fluvoxamine in depressed inpatients.
    van den Broek WW; Birkenhäger TK; Mulder PG; Bruijn JA; Moleman P
    Psychopharmacology (Berl); 2004 Oct; 175(4):481-6. PubMed ID: 15243735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients.
    Claghorn JL; Earl CQ; Walczak DD; Stoner KA; Wong LF; Kanter D; Houser VP
    J Clin Psychopharmacol; 1996 Apr; 16(2):113-20. PubMed ID: 8690826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A self-controlled, naturalistic study of selective serotonin reuptake inhibitors versus tricyclic antidepressants.
    Faravelli C; Cosci F; Ciampelli M; Scarpato MA; Spiti R; Ricca V
    Psychother Psychosom; 2003; 72(2):95-101. PubMed ID: 12601227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Onset of clinical effects and plasma concentration of fluvoxamine in Japanese patients.
    Katoh Y; Uchida S; Kawai M; Takei N; Mori N; Kawakami J; Kagawa Y; Yamada S; Namiki N; Hashimoto H
    Biol Pharm Bull; 2010; 33(12):1999-2002. PubMed ID: 21139240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lithium addition to a tricyclic antidepressant results in optimal efficacy.
    Birkenhäger TK; Van Den Broek WW
    Acta Psychiatr Scand; 2011 Jan; 123(1):83; author reply 83. PubMed ID: 20880071
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of imipramine, fluvoxamine and depressive mood on autonomic cardiac functioning in major depressive disorder.
    Volkers AC; Tulen JH; van den Broek WW; Bruyn JA; Passchier J; Pepplinkhuizen L
    Pharmacopsychiatry; 2004 Jan; 37(1):18-25. PubMed ID: 14750044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mood disorders].
    Passerieux C; Hardy-Baylé MC
    Rev Prat; 2008 Oct; 58(16):1809-14. PubMed ID: 19143154
    [No Abstract]   [Full Text] [Related]  

  • 14. Gender differences in treatment response to sertraline versus imipramine in chronic depression.
    Kornstein SG; Schatzberg AF; Thase ME; Yonkers KA; McCullough JP; Keitner GI; Gelenberg AJ; Davis SM; Harrison WM; Keller MB
    Am J Psychiatry; 2000 Sep; 157(9):1445-52. PubMed ID: 10964861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic depression and comorbid personality disorders: response to sertraline versus imipramine.
    Russell JM; Kornstein SG; Shea MT; McCullough JP; Harrison WM; Hirschfeld RM; Keller MB
    J Clin Psychiatry; 2003 May; 64(5):554-61. PubMed ID: 12755659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant efficacy in relation to item analysis and severity of depression: a placebo-controlled trial of fluvoxamine versus imipramine.
    Kasper S; Möller HJ; Montgomery SA; Zondag E
    Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():3-12. PubMed ID: 7622821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of the effectiveness of two treatment strategies in inpatients with a depressive disorder. A double-blind study of imipramine followed by lithium addition versus fluvoxamine followed by lithium addition].
    Birkenhäger TK; van den Broek WW; Mulder PG; Bruijn JA; Moleman P
    Tijdschr Psychiatr; 2006; 48(4):271-81. PubMed ID: 16955991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National patterns in antidepressant treatment by psychiatrists and general medical providers: results from the national comorbidity survey replication.
    Mojtabai R; Olfson M
    J Clin Psychiatry; 2008 Jul; 69(7):1064-74. PubMed ID: 18399725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression.
    Russell JM; Koran LM; Rush J; Hirschfeld RM; Harrison W; Friedman ES; Davis S; Keller M
    Depress Anxiety; 2001; 13(1):18-27. PubMed ID: 11233456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical relevance of antidepressant-induced activation syndrome: from a perspective of bipolar spectrum disorder].
    Tanaka T; Inoue T; Suzuki K; Kitaichi Y; Masui T; Denda K; Koyama T
    Seishin Shinkeigaku Zasshi; 2007; 109(8):730-42. PubMed ID: 17969991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.